1. Home
  2. COEP vs ASNS Comparison

COEP vs ASNS Comparison

Compare COEP & ASNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • ASNS
  • Stock Information
  • Founded
  • COEP 2017
  • ASNS 1998
  • Country
  • COEP United States
  • ASNS United States
  • Employees
  • COEP N/A
  • ASNS N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • ASNS Telecommunications Equipment
  • Sector
  • COEP Health Care
  • ASNS Telecommunications
  • Exchange
  • COEP Nasdaq
  • ASNS Nasdaq
  • Market Cap
  • COEP 8.1M
  • ASNS 8.4M
  • IPO Year
  • COEP N/A
  • ASNS 2022
  • Fundamental
  • Price
  • COEP $0.20
  • ASNS $1.40
  • Analyst Decision
  • COEP
  • ASNS
  • Analyst Count
  • COEP 0
  • ASNS 0
  • Target Price
  • COEP N/A
  • ASNS N/A
  • AVG Volume (30 Days)
  • COEP 356.1K
  • ASNS 344.7K
  • Earning Date
  • COEP 11-07-2024
  • ASNS 11-12-2024
  • Dividend Yield
  • COEP N/A
  • ASNS N/A
  • EPS Growth
  • COEP N/A
  • ASNS N/A
  • EPS
  • COEP N/A
  • ASNS N/A
  • Revenue
  • COEP N/A
  • ASNS $6,019,000.00
  • Revenue This Year
  • COEP N/A
  • ASNS N/A
  • Revenue Next Year
  • COEP N/A
  • ASNS N/A
  • P/E Ratio
  • COEP N/A
  • ASNS N/A
  • Revenue Growth
  • COEP N/A
  • ASNS N/A
  • 52 Week Low
  • COEP $0.15
  • ASNS $0.36
  • 52 Week High
  • COEP $1.38
  • ASNS $4.60
  • Technical
  • Relative Strength Index (RSI)
  • COEP 59.22
  • ASNS 46.65
  • Support Level
  • COEP $0.17
  • ASNS $1.26
  • Resistance Level
  • COEP $0.19
  • ASNS $1.43
  • Average True Range (ATR)
  • COEP 0.01
  • ASNS 0.07
  • MACD
  • COEP 0.00
  • ASNS -0.00
  • Stochastic Oscillator
  • COEP 78.00
  • ASNS 66.67

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About ASNS Actelis Networks Inc.

Actelis Networks Inc is a networking solutions company with a mission to enable communication for Internet of Things, or IoT, projects, deployed over wide areas such as cities, campuses, airports, military bases, roads, and rail. Its networking solutions use a combination of newly deployed fiber infrastructure and existing copper and coaxial lines to create a cost-effective, secure, and quick-to-deploy network. Its solutions also offer end-to-end network security to protect critical IoT data, utilizing a powerful combination of coding and encryption technologies, applied as required on both new and existing infrastructure within the hybrid-fiber-copper network. The Company operates as one operating segment developing and marketing access broadband equipment for copper and fiber networks.

Share on Social Networks: